Related Experiment Video
Updated: Jul 12, 2026

11:13
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Calciphylaxis mimicking inflammatory breast cancer
Luis A Bonilla1, Diana Dickson-Witmer, Dennis R Witmer
1Department of Surgery, Christiana Care Health System, Newark, Delaware, USA. luis.a.bonilla@gmail.com
The Breast Journal
|September 1, 2007
Summary
Calciphylaxis, a rare vascular disorder, can mimic inflammatory breast cancer in patients with end-stage renal disease. This case highlights the first calciphylaxis recurrence post-parathyroidectomy, suggesting careful evaluation for secondary hyperparathyroidism.
Area of Science:
- Nephrology
- Dermatology
- Pathology
Background:
- Calciphylaxis is a rare, severe condition involving microvascular calcification and tissue necrosis.
- It often presents in patients with end-stage renal disease (ESRD) and secondary hyperparathyroidism.
- Typical symptoms include painful skin lesions with a livedo reticularis pattern.
Observation:
- A 59-year-old female patient with ESRD presented with symptoms mimicking inflammatory breast cancer.
- Initial biopsy and mastectomy revealed calciphylaxis, not malignancy.
- The patient experienced recurrent hyperparathyroidism, necessitating a re-parathyroidectomy with reimplantation.
Findings:
- This case represents the first documented instance of calciphylaxis recurrence following subtotal parathyroidectomy.
- The findings underscore the complex interplay between ESRD, hyperparathyroidism, and calciphylaxis.
- The breast pathology was ultimately attributed to calciphylaxis, despite initial suspicion of cancer.
Implications:
- Patients with ESRD and breast pathology resembling inflammation/necrosis, without malignancy, should be screened for secondary hyperparathyroidism.
- Total parathyroidectomy with reimplantation is recommended for managing recurrent hyperparathyroidism in such cases.
- Mastectomy should be reserved for persistent symptoms, necrosis, or infection unresponsive to other treatments.